Literature DB >> 19591577

MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia.

Gordon A Awandare1, Jeremy J Martinson, Tom Were, Collins Ouma, Gregory C Davenport, John M Ong'echa, Wenkui Wang, Lin Leng, Robert E Ferrell, Richard Bucala, Douglas J Perkins.   

Abstract

BACKGROUND: Severe malarial anemia (SMA) resulting from Plasmodium falciparum infection is one of the leading causes of childhood mortality in sub-Saharan Africa. The innate immune mediator macrophage migration inhibitory factor (MIF) plays a critical role in the pathogenesis of SMA.
METHODS: To investigate the influence of MIF genetic variation on susceptibility to SMA, haplotypes of the MIF -173G/C and -794CATT5-8 polymorphisms were examined in a cohort of Kenyan children.
RESULTS: A statistically significant relationship between increasing frequencies of longer CATT repeats at -794 and increasing severity of malarial anemia was observed. In addition, there was a strong association between lower MIF concentrations and longer CATT repeats. Multivariate logistic regression analyses demonstrated that the 6G haplotype (ie, MIF -794CATT6/-173G) was associated with protection against SMA, whereas carriers of the 7C or 8C haplotype had increased risk of developing SMA. Furthermore, carriers of the 7C or 8C haplotype had reduced plasma MIF levels during acute disease.
CONCLUSIONS: The findings demonstrate that variation in the MIF promoter influences susceptibility to SMA and peripheral MIF production. However, the MIF -173 and -794 polymorphisms appear to have both independent and interactive effects on different measures of disease severity, suggesting that MIF plays a complex role in malarial pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19591577      PMCID: PMC3607439          DOI: 10.1086/600894

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Protective effects of the sickle cell gene against malaria morbidity and mortality.

Authors:  Michael Aidoo; Dianne J Terlouw; Margarette S Kolczak; Peter D McElroy; Feiko O ter Kuile; Simon Kariuki; Bernard L Nahlen; Altaf A Lal; Venkatachalam Udhayakumar
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

2.  Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Authors:  T Calandra; B Echtenacher; D L Roy; J Pugin; C N Metz; L Hültner; D Heumann; D Männel; R Bucala; M P Glauser
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

3.  Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa.

Authors:  R W Snow; J A Omumbo; B Lowe; C S Molyneux; J O Obiero; A Palmer; M W Weber; M Pinder; B Nahlen; C Obonyo; C Newbold; S Gupta; K Marsh
Journal:  Lancet       Date:  1997-06-07       Impact factor: 79.321

4.  Role for macrophage migration inhibitory factor in asthma.

Authors:  Y Mizue; S Ghani; L Leng; C McDonald; P Kong; J Baugh; S J Lane; J Craft; J Nishihira; S C Donnelly; Z Zhu; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

5.  Association of FCgamma receptor IIA (CD32) polymorphism with malarial anemia and high-density parasitemia in infants and young children.

Authors:  Collins Ouma; Christopher C Keller; Dorothy A Opondo; Tom Were; Richard O Otieno; Michael F Otieno; Alloys S S Orago; John M Ong'Echa; John M Vulule; Robert E Ferrell; Douglas J Perkins
Journal:  Am J Trop Med Hyg       Date:  2006-04       Impact factor: 2.345

6.  Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria.

Authors:  Richard O Otieno; Collins Ouma; John M Ong'echa; Christopher C Keller; Tom Were; Eliud N Waindi; Marian G Michaels; Richard D Day; John M Vulule; Douglas J Perkins
Journal:  AIDS       Date:  2006-01-09       Impact factor: 4.177

7.  Manifestation and outcome of severe malaria in children in northern Ghana.

Authors:  Frank P Mockenhaupt; Stephan Ehrhardt; Jana Burkhardt; Samuel Y Bosomtwe; Stephen Laryea; Sylvester D Anemana; Rowland N Otchwemah; Jakob P Cramer; Ekkehart Dietz; Sabine Gellert; Ulrich Bienzle
Journal:  Am J Trop Med Hyg       Date:  2004-08       Impact factor: 2.345

8.  Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium.

Authors:  Heidrun Koebernick; Leander Grode; John R David; Wolfgang Rohde; Michael S Rolph; Hans-Willi Mittrücker; Stefan H E Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

9.  Parasitemia, anemia, and malarial anemia in infants and young children in a rural holoendemic Plasmodium falciparum transmission area.

Authors:  John Michael Ong'echa; Christopher C Keller; Tom Were; Collins Ouma; Richard O Otieno; Zachary Landis-Lewis; Daniel Ochiel; Jamie L Slingluff; Stephen Mogere; George A Ogonji; Alloys S Orago; John M Vulule; Sandra S Kaplan; Richard D Day; Douglas J Perkins
Journal:  Am J Trop Med Hyg       Date:  2006-03       Impact factor: 2.345

10.  A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.

Authors:  Michael A McDevitt; Jianlin Xie; Shanmugasundaram Ganapathy-Kanniappan; Ganapathy Shanmugasundaram; Jason Griffith; Aihua Liu; Courtney McDonald; Philip Thuma; Victor R Gordeuk; Christine N Metz; Robert Mitchell; Jeffrey Keefer; John David; Lin Leng; Richard Bucala
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307

View more
  39 in total

1.  Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.

Authors:  Diane Tshikudi Malu; Benoit Bélanger; François Desautels; Karine Kelendji; Esther Dalko; Jaime Sanchez-Dardon; Lin Leng; Richard Bucala; Abhay R Satoskar; Tatiana Scorza
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

Review 2.  Macrophage migration inhibitory factor (MIF): a promising biomarker.

Authors:  Gerrit Grieb; Melanie Merk; Jürgen Bernhagen; Richard Bucala
Journal:  Drug News Perspect       Date:  2010-05

3.  Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus.

Authors:  Jie Yao; Lin Leng; Maor Sauler; Weiling Fu; Junsong Zheng; Yi Zhang; Xin Du; Xiaoqing Yu; Patty Lee; Richard Bucala
Journal:  J Clin Invest       Date:  2016-01-11       Impact factor: 14.808

4.  Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction.

Authors:  James M Harper; J Erby Wilkinson; Richard A Miller
Journal:  FASEB J       Date:  2010-03-10       Impact factor: 5.191

5.  A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activity.

Authors:  Pathricia Veronica Tilstam; Georgios Pantouris; Michael Corman; Monica Andreoli; Keyvan Mahboubi; Gary Davis; Xin Du; Lin Leng; Elias Lolis; Richard Bucala
Journal:  J Biol Chem       Date:  2019-10-02       Impact factor: 5.157

6.  Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis.

Authors:  Rituparna Das; Mi-Sun Koo; Bae Hoon Kim; Shevin T Jacob; Selvakumar Subbian; Jie Yao; Lin Leng; Rebecca Levy; Charles Murchison; William J Burman; Christopher C Moore; W Michael Scheld; John R David; Gilla Kaplan; John D MacMicking; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-23       Impact factor: 11.205

7.  Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.

Authors:  Antoine Sreih; Rana Ezzeddine; Lin Leng; Avery LaChance; Geraldine Yu; Yuka Mizue; Lakshman Subrahmanyan; Bernardo A Pons-Estel; Anna-Karin Abelson; Iva Gunnarsson; Elisabet Svenungsson; Joshua Cavett; Stuart Glenn; Lin Zhang; Ruth Montgomery; Andras Perl; Jane Salmon; Marta E Alarcón-Riquelme; John B Harley; Richard Bucala
Journal:  Arthritis Rheum       Date:  2011-12

Review 8.  Malaria, erythrocytic infection, and anemia.

Authors:  Kasturi Haldar; Narla Mohandas
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

Review 9.  MIF, MIF alleles, and prospects for therapeutic intervention in autoimmunity.

Authors:  Richard Bucala
Journal:  J Clin Immunol       Date:  2012-09-12       Impact factor: 8.317

10.  A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study.

Authors:  Lutz E Lehmann; Malte Book; Wolfgang Hartmann; Stefan U Weber; Jens-Christian Schewe; Sven Klaschik; Andreas Hoeft; Frank Stüber
Journal:  J Transl Med       Date:  2009-11-26       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.